BeneChill, a privately held medical device company, was established in 2004 to develop, manufacture, and sell novel rapid cooling technologies that increase the rate of neurologically intact survival after an ischemic event, such as cardiac arrest.

BeneChill’s groundbreaking technology, the RhinoChill® IntraNasal Cooling System is designed to deliver effective cooling faster and earlier than conventional cooling methods. Through a lightweight, portable design and unique intra-nasal delivery of a proprietary coolant, the RhinoChill® System enables both rescue services and hospital personnel to easily and effectively initiate cooling.